Backgound
Glaucoma is the world’s leading cause of irreversible blindness, with primary angle-closure glaucoma being particularly prevalent among Asian populations, posing a serious threat to the visual function and quality of life of patients in China. Despite ongoing advancements in related research, challenges remain in understanding its pathogenesis, achieving early detection, enabling precise diagnosis, and standardizing prevention and treatment. To further promote academic exchange and collaborative innovation in the field of primary angle-closure glaucoma, a non-profit collaborative research network—the Primary Angle-Closure Disease (PACD) Research Club—has been formally established. This initiative is led by Academician Wang Ningli of the Chinese Academy of Engineering, Professor Li Shuning’s team from Beijing Tongren Hospital affiliated with Capital Medical University, and Professor Ying Han from the University of California, San Francisco.
PACD Research Club is a non-profit collaborative initiative voluntarily established by ophthalmic professionals, comprising clinicians, lab researchers, and public health scholars dedicated to primary angle-closure disease (PACD)/ spectrum of primary angle-closure (sPAC). The organization is committed to:
We welcome:
Clinicians (especially glaucoma specialists)；Public Health Researchers；AI/Imaging Technology Experts；Industry Partners (drug/device)；Non-Profit Organizations
To access:
Leading ophthalmology expert and strategic initiator of the PACD collaborative network.
Core clinical investigator focused on glaucoma diagnosis, care pathways, and translational collaboration.
International collaborator advancing cross-border PACD research and innovation.
Clinicians, researchers, public health experts, and industry partners are all welcome. Submit your application and track its status through a secure email sign-in link.
